Literature DB >> 2944915

Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.

F A Tausk, A McCutchan, P Spechko, R D Schreiber, I Gigli.   

Abstract

We studied levels of erythrocyte C3b receptors (E-CR1) and correlated them to the level of circulating immune complexes (CIC) and complement activation in patients with or at risk for acquired immunodeficiency syndrome (AIDS). A significant reduction was found in patients with AIDS (185 +/- 93 CR1/cell), AIDS-related complex, and generalized lymphadenopathy, whereas healthy male homosexuals or normal controls had 434 +/- 193 and 509 +/- 140 CR1/cell, respectively (P less than 0.001). Family studies indicate that this defect is acquired. Reduction in E-CR1 was associated with increased levels of CIC when assayed by binding to Raji cells, but not when tested by C1q binding. Complement activation was assessed by levels of C3bi/C3d-g in plasma, measured with a monoclonal antibody specific for a neoantigen in C3d. AIDS patients had increased C3 activation (2.68 +/- 1.67%) when compared with normal controls (0.9 +/- 0.22%) (P less than 0.01). The decreased E-CR1, the presence of CIC, and C3 activation suggest that complement activation by immune complexes may play a role in the clinical expression of the disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944915      PMCID: PMC423736          DOI: 10.1172/JCI112688

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

Review 1.  The chemistry and biology of complement receptors.

Authors:  R D Schreiber
Journal:  Springer Semin Immunopathol       Date:  1984

2.  Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome.

Authors:  S G Pahwa; M T Quilop; M Lange; R N Pahwa; M H Grieco
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

3.  Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

Authors:  J G Wilson; R M Jack; W W Wong; P H Schur; D T Fearon
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

4.  Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody.

Authors:  S Minota; C Terai; Y Nojima; K Takano; E Takai; Y Miyakawa; F Takaku
Journal:  Arthritis Rheum       Date:  1984-12

5.  On the mechanism of thrombocytopenic purpura in sexually active homosexual men.

Authors:  C M Walsh; M A Nardi; S Karpatkin
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

6.  Leprosy: altered complement receptors in disseminated disease.

Authors:  F Tausk; T Hoffmann; R Schreiber; I Gigli
Journal:  J Invest Dermatol       Date:  1985-07       Impact factor: 8.551

7.  Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.

Authors:  M J Walport; G D Ross; C Mackworth-Young; J V Watson; N Hogg; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

8.  Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.

Authors:  J D Tamerius; M K Pangburn; H J Müller-Eberhard
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.

Authors:  G D Ross; W J Yount; M J Walport; J B Winfield; C J Parker; C R Fuller; R P Taylor; B L Myones; P J Lachmann
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  Glomerular lesions in the acquired immunodeficiency syndrome.

Authors:  V Pardo; M Aldana; R M Colton; M A Fischl; D Jaffe; L Moskowitz; G T Hensley; J J Bourgoignie
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

View more
  28 in total

1.  Expression and localization of proteins of the complement system in human skin.

Authors:  N Dovezenski; R Billetta; I Gigli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 2.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

3.  Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).

Authors:  I Csípö; E Kiss; P Soltész; P Antal-Szalmás; G Szegedi; J H Cohen; R P Taylor; M Kávai
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

4.  Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.

Authors:  R P Taylor; W M Sutherland; C J Reist; D J Webb; E L Wright; R H Labuguen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients.

Authors:  J E Teixeira; R Martinez; L M Câmara; J E Barbosa
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 6.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Mapping epitopes for 20 monoclonal antibodies to CR1.

Authors:  M Nickells; R Hauhart; M Krych; V B Subramanian; K Geoghegan-Barek; H C Marsh; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

8.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.

Authors:  J Schmitz; J P Zimmer; B Kluxen; S Aries; M Bögel; I Gigli; H Schmitz
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?

Authors:  P E Ruuska; I Ikäheimo; S Silvennoinen-Kassinen; M L Käär; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

10.  Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).

Authors:  C-H Chen; I Ghiran; F J M Beurskens; G Weaver; J A Vincent; A Nicholson-Weller; L B Klickstein
Journal:  Clin Exp Immunol       Date:  2007-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.